Leander Lauffer leads and supports MVI's business negotiations for the development of collaborative commercial relationships with pharmaceutical and biotechnology companies, academic institutions, and governmental entities. He also focuses on development and implementation of intellectual-property and commercialization strategies for MVI’s complex vaccine development projects.
Prior to joining MVI, Leander led the business development function at Trubion Pharmaceuticals, successfully negotiating a major strategic partnership with a global pharmaceutical company. Leander also brings to MVI extensive experience in the business development and commercialization of vaccines. He was formerly vice-president of business development at Chiron and served as head of business development for the Vaccine Business Unit at Behringwerke AG in Germany.
Leander received a PhD in biology from Freie Universität Berlin, Germany, and an MS in biology from Universität Konstanz, Germany.